Back To Top

Tip: To quickly find your search term on this page, press "Ctrl" + "f" on your keyboard (Command + "f" on a Mac) and use the find bar.
Obatoclax (GX15-070) Catalog#: A-1022
         Obatoclax (GX15-070) is an inhibit of the Bcl-2.
OICR-9429 Catalog#: A-9063
         OICR-9429 is a cell penetrant, potent and selective antagonist of the interaction of WDR5 (WD repeat domain 5) with peptide regions of MLL and Histone 3 that potently binds to WDR5.
Olmutinib Catalog#: A-6040
         Olmutinib is an inhibitor of mutant EGFR
Omarigliptin(MK-3102) Catalog#: A-1949
         Omarigliptin, also known as MK-3102, is a potent and long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes.
Omecamtiv mecarbil(CK-1827452) Catalog#: A-1956
         Omecamtiv mecarbil, also known as CK-1827452, is a cardiac specific myosin activator.
ONX-0912 Catalog#: A-1368
         Oprozomib (ONX 0912), a tripeptide epoxyketone, is an ORALLY ACTIVE and irreversible inhibitor of 20S proteasome inhibitor targeting primarily chymotrypsin-like activity.
OPB-31121 Catalog#: A-1104
         OPB-31121 is a Stat3 in clinical trials
Oridonin Catalog#: A-3019
         Oridonin has potent anti-tumor activity. Oridonin targets AE (AML1-ETO) oncoprotein
OSI-027 Catalog#: A-1065
         OSI-027 is an orally bioavailable mTORC1/C2 kinase inhibitor with anti-tumor activity.
OSI-906(Linsitinib) Catalog#: A-1058
         OSI-906 is a potent, selective orally active inhibitor of the insulin-like growth factor-1 receptor (IGF-1R).
OSU-03012 Catalog#: A-1209
         OSU-03012 is a PDK1 inhibitor in clinical trials.
OTX-015 Catalog#: A-1349
         OTX-015 is an orally bioavailable and small molecule inhibitor of bromodomain and extra terminal domain (BET) family proteins with EC50 values of 10-19 nM for BRD2, BRD3, and BRD4.
Oxaliplatin Catalog#: A-2007
         Oxaliplatin is an anti-cancer chemotherapy drug and is classified as an alkylating agent.

*Note: These products are for research purposes only, not for human consumption.